ClinicalTrials.Veeva

Menu

Optimization of Drug Treatment in Hospitalized Elderly (OMAGE)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Global Medical Assessment of Elderly Frail Patients

Treatments

Procedure: drug - oriented multifaceted intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT00450034
P060247

Details and patient eligibility

About

A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population, compared with usual care.

Full description

Drug treatment in elderly is not yet optimal. 20 to 30% of admissions of elderly aged over 80 are related to drug problems, most of them being preventable. To decrease drug related hospitalizations need iatrogenic prevention, compliance improvement, and underuse decrease. A multifaceted intervention has been designed, included three dimensions : 1/ drug optimization 2/ patient and/or caregiver education and 3/ better coordination with home health professionals before discharge.

A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population, compared with usual care.

Enrollment

665 patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients hospitalized as a matter of urgency in unity(unit) of geriatrics acute
  • Patients of more than 70 years old
  • Hospitalization in the Unity(Unit) of Geriatrics foreseen(planned) superior acute in 5 days
  • enlightened assent writing and signed
  • preliminary medical examination

Exclusion criteria

  • Patients in scheduled(programmed) hospitalization
  • Patient in palliative care
  • Patient whose vital forecast is engaged(opened) in 3 months
  • Patient already include during a previous hospitalization Patient already included in a study concerning the therapeutic care
  • Followed medical impossible (refusal of care, absence of alive regular, patient doctor abroad)
  • not membership to a regime of Social Security or CMU
  • Patient not speaking French

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

665 participants in 1 patient group

1
Experimental group
Treatment:
Procedure: drug - oriented multifaceted intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems